Frustratingly, no binding affinity could be measured for the hit fragments of interest. However, also for fragments inspired by the potent ligands platencin and platensimycin no binding affinity could be determined, albeit the crystal structure of one of the ligand in complex with FabF was obtained (Figure ). Using this as starting point, it should be possible to optimise the here discovered fragment hits into potent inhibitors.